<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>COVID-19 Vaccine Moderna 5791 - Product Information final (v14)</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:SimSun;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"\@SimSun";
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:"\@MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
h1
	{mso-style-link:"Heading 1 Char";
	margin-right:0in;
	margin-left:0in;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
h6
	{mso-style-link:"Heading 6 Char";
	margin-top:2.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	line-height:13.0pt;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Cambria",serif;
	color:#243F60;
	font-weight:normal;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-name:"Comment Text\,Annotationtext";
	mso-style-link:"Comment Text Char\,Annotationtext Char";
	margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Arial",sans-serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	line-height:13.0pt;
	font-size:8.0pt;
	font-family:"Arial",sans-serif;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	color:green;
	font-style:italic;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;}
p
	{margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-link:"Comment Subject Char";
	margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{margin:0in;
	line-height:13.0pt;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoRMPane, li.MsoRMPane, div.MsoRMPane
	{margin:0in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MemoHeaderStyle, li.MemoHeaderStyle, div.MemoHeaderStyle
	{mso-style-name:MemoHeaderStyle;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.9pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	font-variant:small-caps;
	font-weight:bold;}
p.EMEAEnBodyText, li.EMEAEnBodyText, div.EMEAEnBodyText
	{mso-style-name:"EMEA En Body Text";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.BodytextAgency, li.BodytextAgency, div.BodytextAgency
	{mso-style-name:"Body text \(Agency\)";
	mso-style-link:"Body text \(Agency\) Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;}
span.BodytextAgencyChar
	{mso-style-name:"Body text \(Agency\) Char";
	mso-style-link:"Body text \(Agency\)";
	font-family:"Verdana",sans-serif;}
p.DraftingNotesAgency, li.DraftingNotesAgency, div.DraftingNotesAgency
	{mso-style-name:"Drafting Notes \(Agency\)";
	mso-style-link:"Drafting Notes \(Agency\) Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	font-size:11.0pt;
	font-family:"Courier New";
	color:#339966;
	font-style:italic;}
span.DraftingNotesAgencyChar
	{mso-style-name:"Drafting Notes \(Agency\) Char";
	mso-style-link:"Drafting Notes \(Agency\)";
	font-family:"Courier New";
	color:#339966;
	font-style:italic;}
p.NormalAgency, li.NormalAgency, div.NormalAgency
	{mso-style-name:"Normal \(Agency\)";
	mso-style-link:"Normal \(Agency\) Char";
	margin:0in;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;}
p.TableheadingrowsAgency, li.TableheadingrowsAgency, div.TableheadingrowsAgency
	{mso-style-name:"Table heading rows \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.TabletextrowsAgency, li.TabletextrowsAgency, div.TabletextrowsAgency
	{mso-style-name:"Table text rows \(Agency\)";
	margin:0in;
	line-height:14.0pt;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;}
span.NormalAgencyChar
	{mso-style-name:"Normal \(Agency\) Char";
	mso-style-link:"Normal \(Agency\)";
	font-family:"Verdana",sans-serif;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char\,Annotationtext Char";
	mso-style-link:"Comment Text\,Annotationtext";
	font-family:"Times New Roman",serif;}
span.CommentSubjectChar
	{mso-style-name:"Comment Subject Char";
	mso-style-link:"Comment Subject";
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.C-BodyText, li.C-BodyText, div.C-BodyText
	{mso-style-name:"C-Body Text";
	mso-style-link:"C-Body Text Char1";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:14.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.C-BodyTextChar1
	{mso-style-name:"C-Body Text Char1";
	mso-style-link:"C-Body Text";
	font-family:"Times New Roman",serif;}
span.Mention1
	{mso-style-name:Mention1;
	color:#2B579A;
	background:#E6E6E6;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.normaltextrun
	{mso-style-name:normaltextrun;}
p.paragraph, li.paragraph, div.paragraph
	{mso-style-name:paragraph;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.eop
	{mso-style-name:eop;}
p.TableParagraph, li.TableParagraph, div.TableParagraph
	{mso-style-name:"Table Paragraph";
	margin:0in;
	text-align:center;
	text-autospace:none;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
span.UnresolvedMention1
	{mso-style-name:"Unresolved Mention1";
	color:#605E5C;
	background:#E1DFDD;}
p.Default, li.Default, div.Default
	{mso-style-name:Default;
	margin:0in;
	text-autospace:none;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:black;}
span.UnresolvedMention2
	{mso-style-name:"Unresolved Mention2";
	color:#605E5C;
	background:#E1DFDD;}
span.Mention2
	{mso-style-name:Mention2;
	color:#2B579A;
	background:#E1DFDD;}
span.Heading6Char
	{mso-style-name:"Heading 6 Char";
	mso-style-link:"Heading 6";
	font-family:"Cambria",serif;
	color:#243F60;}
span.UnresolvedMention3
	{mso-style-name:"Unresolved Mention3";
	color:#605E5C;
	background:#E1DFDD;}
span.Mention3
	{mso-style-name:Mention3;
	color:#2B579A;
	background:#E1DFDD;}
span.UnresolvedMention4
	{mso-style-name:"Unresolved Mention4";
	color:#605E5C;
	background:#E1DFDD;}
span.Mention4
	{mso-style-name:Mention4;
	color:#2B579A;
	background:#E1DFDD;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:595.35pt 842.0pt;
	margin:56.7pt 70.9pt 56.7pt 70.9pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>

</head>

<body lang=EN-US link=blue vlink=purple style='word-wrap:break-word'>

<div class=WordSection1>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>ANNEX I</span></b></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>SUMMARY OF PRODUCT CHARACTERISTICS</span></b></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:green'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='line-height:normal'><span lang=DE><img width=21
height=18 id="Picture 1"
src="COVID-19%20Vaccine%20Moderna%205791%20-%20Product%20Information%20final_files/image002.png"></span><span
lang=EN-GB>This medicinal product is subject to additional monitoring. This
will allow quick identification of new safety information. Healthcare
professionals are asked to report any suspected adverse reactions. See section
4.8 for how to report adverse reactions.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>1.       NAME OF </span></b><b><span lang=EN-GB>THE
MEDICINAL PRODUCT</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>COVID-19 Vaccine
Moderna dispersion for injection</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>COVID-19 mRNA Vaccine
(nucleoside modified)</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>2.       QUALITATIVE AND QUANTITATIVE COMPOSITION</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>This is a
multidose vial which contains 10 doses of 0.5&nbsp;mL.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>One dose (0.5
mL) contains 100 micrograms of messenger RNA (mRNA) (embedded in <a
name="_Hlk60809885">SM-102 lipid nanoparticles</a>). </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Single-stranded,
5’-capped messenger RNA (mRNA) produced using a cell-free <i>in vitro</i>
transcription from the corresponding DNA templates, encoding the viral spike
(S) protein of SARS-CoV-2.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>For the full
list of excipients, see section 6.1.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>3.       PHARMACEUTICAL FORM</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Dispersion for
injection</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>White to off
white dispersion (pH: 7.0 – 8.0).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB style='text-transform:uppercase'>4.       </span></b><b><span
lang=EN-GB>CLINICAL PARTICULARS</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.1     Therapeutic indications</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>COVID-19 Vaccine
Moderna is indicated for active immunisation to prevent COVID-19 caused by
SARS-CoV-2 in individuals 18 years of age and older.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The use of this
vaccine should be in accordance with official recommendations.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.2     Posology
and method of administration</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Posology</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><i><span lang=EN-GB>Individuals
18 years of age and older</span></i></p>

<p class=MsoNormal><span lang=EN-GB>COVID-19 Vaccine Moderna is administered as
a course of 2 doses (0.5&nbsp;mL each). It is recommended to administer the
second dose 28 days after the first dose (see sections 4.4 and 5.1). </span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal><span lang=EN-GB>There are no data available on the
interchangeability of COVID-19 Vaccine Moderna with other COVID-19 vaccines to
complete the vaccination course. Individuals who have received the first dose
of COVID-19 Vaccine Moderna should receive the second dose of COVID-19 Vaccine
Moderna to complete the vaccination course. </span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal><i><span lang=EN-GB>Paediatric population</span></i></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>The safety and
efficacy of COVID-19 Vaccine Moderna in children and adolescents less than
18&nbsp;years of age have not yet been established. No data are available. </span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid;text-autospace:
none'><i><span lang=EN-GB>Elderly population</span></i></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>No dosage
adjustment is required in elderly individuals &#8805;65 years of age.</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Method of
administration </span></u></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The vaccine </span><span
lang=EN-GB>should be administered intramuscularly. The preferred site is the
deltoid muscle of the upper arm. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not
administer this vaccine intravascularly, subcutaneously or intradermally. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The vaccine
should not be mixed in the same syringe with any other vaccines or medicinal
products.</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>For precautions to be taken before administering the vaccine, see
section 4.4.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>For instructions regarding thawing,
handling and disposal of the vaccine, see section 6.6.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.3     Contraindications</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Hypersensitivity
to the active substance or to any of the excipients listed in section 6.1.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.4</span></b><b><span lang=EN-GB>     </span><span
lang=EN-GB>Special warnings and precautions for use</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Traceability</span></u></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In order to
improve the traceability of biological medicinal products, the name and the
batch number of the administered product should be clearly recorded.</span></p>

<p class=MsoNormal style='line-height:normal'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Hypersensitivity
and anaphylaxis</span></u></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Anaphylaxis has
been reported. Appropriate medical treatment and supervision should always be
readily available in case of an anaphylactic reaction following administration
of the vaccine. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Close
observation for at least 15 minutes is recommended following vaccination. </span><span
lang=EN-GB>The second dose of the vaccine should not be given to those who have
experienced anaphylaxis to the first dose of </span><span lang=EN-GB>COVID-19
Vaccine Moderna</span><span lang=EN-GB>.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Anxiety-related
reactions</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>Anxiety-related reactions, including vasovagal reactions (syncope),
hyperventilation or stress</span><span lang=EN-GB style='font-family:"Cambria Math",serif'>&#8208;</span><span
lang=EN-GB>related reactions may occur in association with vaccination as a
psychogenic response to the needle injection. It is important that precautions
are in place to avoid injury from fainting.</span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Concurrent illness</span></u></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Vaccination
should be postponed in individuals suffering from acute severe febrile illness
or acute infection. The presence of a minor infection and/or low-grade fever
should not delay vaccination.</span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Thrombocytopenia
and coagulation disorders</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>As with other
intramuscular injections</span><span lang=EN-GB>, the vaccine should be given
with caution in individuals receiving anticoagulant therapy or those with
thrombocytopenia or any coagulation disorder (such as haemophilia) because
bleeding or bruising may occur following an intramuscular administration in
these individuals.</span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Immunocompromised
individuals</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The efficacy,
safety and immunogenicity of the vaccine has not been assessed in
immunocompromised individuals, including those receiving immunosuppressant
therapy. The efficacy of COVID-19 Vaccine Moderna may be lower in
immunosuppressed individuals.</span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Duration of
protection</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The duration of
protection afforded by the vaccine is unknown as it is still being determined
by ongoing clinical trials.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Limitations
of vaccine effectiveness</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Individuals may
not be fully protected until 14 days after their second dose. As with all
vaccines, vaccination with COVID-19 Vaccine Moderna may not protect all vaccine
recipients. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='page-break-after:avoid'><u><span lang=EN-GB>Excipients
with known effect</span></u></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='page-break-after:avoid'><i><span lang=EN-GB>Sodium </span></i></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>This vaccine contains
less than 1 mmol sodium (23 mg) per 0.5 mL dose, that is to say, essentially
‘sodium-free’. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.5     Interaction with other medicinal products
and other forms of interaction</span></b></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>No interaction
studies have been performed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Concomitant
administration of COVID-19 Vaccine Moderna with other vaccines has not been
studied. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.6     </span></b><b><span lang=EN-GB>Fertility, p</span></b><b><span
lang=EN-GB>regnancy and lactation</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Pregnancy</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>There is limited
experience with use of COVID-19 Vaccine Moderna in pregnant women. </span><span
lang=EN-GB>Animal studies do not indicate direct or indirect harmful effects
with respect to pregnancy, embryo/foetal development, parturition or post-natal
development (see section 5.3). Administration of COVID-19 Vaccine Moderna in
pregnancy should only be considered when the potential benefits outweigh any
potential risks for the mother and foetus.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Breast-feeding</span></u></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>It is unknown
whether COVID-19 Vaccine Moderna is excreted in human milk. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u><span
lang=EN-GB>Fertility</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Animal studies
do not indicate direct or indirect harmful effects with respect to reproductive
toxicity (see section 5.3).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.7     Effects on ability to drive and use machines</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='text-autospace:none'><span lang=EN-GB>COVID-19 Vaccine
Moderna has no or negligible influence on the ability to drive and use
machines. However, some of the effects mentioned under section&nbsp;4.8 may
temporarily affect the ability to drive or use machines.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>4.8     Undesirable
effects</span></b></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph;
line-height:normal;text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u><span
lang=EN-GB style='color:black'>Summary of the safety profile</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The safety of
COVID-19 Vaccine Moderna was evaluated in an ongoing Phase 3 randomised,
placebo-controlled, observer-blind clinical trial conducted in the United
States involving 30,351 participants 18 years of age and older who received at
least one dose of COVID-19 Vaccine Moderna (n=15,185) or placebo (n=15,166)
(NCT04470427). At the time of vaccination, the mean age of the population was
52 years (range 18-95); 22,831 (75.2%) of participants were 18 to 64 years of
age and 7,520 (24.8%) of participants were 65 years of age and older.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The most
frequently reported adverse reactions were pain at the injection site (92%),&nbsp;fatigue
(70%), headache (64.7%),&nbsp;myalgia (61.5%), arthralgia (46.4%), chills (45.4%),
nausea/vomiting (23%), axillary swelling/tenderness (19.8%), fever (15.5%),
injection site swelling (14.7%) and redness (10%). Adverse reactions were
usually mild or moderate in intensity and resolved within a few days after
vaccination. A slightly lower frequency of reactogenicity events was associated
with greater age.&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Overall, there
was a higher incidence of some adverse reactions in younger age groups: the
incidence of&nbsp;axillary swelling/tenderness,&nbsp;fatigue, headache, myalgia,&nbsp;arthralgia,&nbsp;chills,&nbsp;nausea/vomiting
and&nbsp;fever&nbsp;was higher in adults aged 18 to &lt; 65 years than in those
aged 65 years and&nbsp;above.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Local and systemic
adverse reactions were more frequently reported after Dose 2 than after Dose 1.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Tabulated
list of adverse reactions&nbsp;</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The safety
profile presented below is based on data generated in&nbsp;a&nbsp;placebo-
controlled clinical study&nbsp;on&nbsp;30,351&nbsp;adults
&#8805;&nbsp;18&nbsp;years of age.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Adverse
reactions reported are listed according to the following frequency convention:&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Very&nbsp;common
(&#8805;1/10)&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Common (&#8805;1/100
to&nbsp;&lt;1/10)&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Uncommon (&#8805;1/1,000
to&nbsp;&lt;1/100)&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Rare (&#8805;1/10,000
to&nbsp;&lt;1/1,000)&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Very&nbsp;rare (&lt;1/10,000)&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Not known
(cannot be estimated from the available data)</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Within each
frequency grouping, adverse reactions are presented in order of decreasing
seriousness.&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%"
 style='width:100.0%;border-collapse:collapse;border:none'>
 <tr style='height:24.0pt'>
  <td width="38%" valign=top style='width:38.68%;border:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:24.0pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>MedDRA
  System Organ Class<sup>&nbsp;</sup></span></b></p>
  </td>
  <td width="34%" valign=top style='width:34.8%;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 0in 0in 0in;height:24.0pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Frequency&nbsp;</span></b></p>
  </td>
  <td width="26%" valign=top style='width:26.52%;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 0in 0in 0in;height:24.0pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Adverse
  reactions&nbsp;</span></b></p>
  </td>
 </tr>
 <tr style='height:26.5pt'>
  <td width="38%" valign=top style='width:38.68%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:26.5pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Blood and
  lymphatic system disorders&nbsp;</span></b></p>
  </td>
  <td width="34%" valign=top style='width:34.8%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:26.5pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Very
  common&nbsp;</span></p>
  </td>
  <td width="26%" valign=top style='width:26.52%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:26.5pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Lymphadenopathy*
  </span></p>
  </td>
 </tr>
 <tr style='height:32.85pt'>
  <td width="38%" valign=top style='width:38.68%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:32.85pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Immune
  system disorders</span></b></p>
  </td>
  <td width="34%" valign=top style='width:34.8%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:32.85pt'>
  <p class=MsoNormal style='line-height:normal'><span class=normaltextrun><span
  lang=EN-GB>Not known</span></span><span class=eop><span lang=EN-GB>&nbsp;</span></span></p>
  </td>
  <td width="26%" valign=top style='width:26.52%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:32.85pt'>
  <p class=MsoNormal style='line-height:normal'><span class=normaltextrun><span
  lang=EN-GB>Anaphylaxis</span></span><span class=eop><span lang=EN-GB>&nbsp;</span></span></p>
  <p class=MsoNormal style='line-height:normal'><span class=normaltextrun><span
  lang=EN-GB>Hypersensitivity</span></span></p>
  </td>
 </tr>
 <tr style='height:15.25pt'>
  <td width="38%" rowspan=2 valign=top style='width:38.68%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:15.25pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Nervous
  system disorders&nbsp;</span></b></p>
  </td>
  <td width="34%" valign=top style='width:34.8%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:15.25pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Very
  common&nbsp;</span></p>
  </td>
  <td width="26%" valign=top style='width:26.52%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:15.25pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Headache</span></p>
  </td>
 </tr>
 <tr style='height:15.25pt'>
  <td width="34%" valign=top style='width:34.8%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:15.25pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Rare</span></p>
  </td>
  <td width="26%" valign=top style='width:26.52%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:15.25pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Acute
  peripheral facial paralysis**</span></p>
  </td>
 </tr>
 <tr style='height:11.65pt'>
  <td width="38%" valign=top style='width:38.68%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.65pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Gastrointestinal
  disorders&nbsp;</span></b></p>
  </td>
  <td width="34%" valign=top style='width:34.8%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:11.65pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Very
  common&nbsp;</span></p>
  </td>
  <td width="26%" valign=top style='width:26.52%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:11.65pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Nausea/vomiting</span></p>
  </td>
 </tr>
 <tr style='height:11.65pt'>
  <td width="38%" valign=top style='width:38.68%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.65pt'>
  <p class=MsoNormal style='line-height:normal'><span class=normaltextrun><b><span
  lang=EN-GB>Skin and subcutaneous tissue disorders</span></b></span><span
  class=eop><span lang=EN-GB>&nbsp;</span></span></p>
  </td>
  <td width="34%" valign=top style='width:34.8%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:11.65pt'>
  <p class=MsoNormal style='line-height:normal'><span class=normaltextrun><span
  lang=EN-GB>Common&#8239;</span></span><span class=eop><span lang=EN-GB>&nbsp;</span></span></p>
  </td>
  <td width="26%" valign=top style='width:26.52%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:11.65pt'>
  <p class=MsoNormal style='line-height:normal'><span class=normaltextrun><span
  lang=EN-GB>Rash</span></span></p>
  </td>
 </tr>
 <tr style='height:24.7pt'>
  <td width="38%" valign=top style='width:38.68%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:24.7pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Musculoskeletal
  and connective tissue disorders&nbsp;</span></b></p>
  </td>
  <td width="34%" valign=top style='width:34.8%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:24.7pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Very
  common&nbsp;</span></p>
  </td>
  <td width="26%" valign=top style='width:26.52%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:24.7pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Myalgia</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Arthralgia</span></p>
  </td>
 </tr>
 <tr style='height:62.95pt'>
  <td width="38%" rowspan=4 valign=top style='width:38.68%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:62.95pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>General
  disorders and&nbsp;administration site&nbsp;conditions&nbsp;</span></b></p>
  </td>
  <td width="34%" valign=top style='width:34.8%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:62.95pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Very
  common&nbsp;</span></p>
  </td>
  <td width="26%" valign=top style='width:26.52%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:62.95pt'>
  <p class=MsoNormal style='line-height:normal'><a name="_Hlk57632695"><span
  lang=FR>Injection site pain</span></a></p>
  <p class=MsoNormal style='line-height:normal'><span lang=FR>Fatigue</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=FR>Chills</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=FR>Pyrexia</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Injection site
  swelling</span><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:30.1pt'>
  <td width="34%" valign=top style='width:34.8%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:30.1pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Common&nbsp;</span></p>
  </td>
  <td width="26%" valign=top style='width:26.52%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:30.1pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=FR>Injection site
  erythema<span class=normaltextrun><u><span style='color:#D13438'>,</span></u>
  Injection site urticaria, Injection site </span></span><span
  class=normaltextrun><span lang=FR>rash</span></span></p>
  </td>
 </tr>
 <tr style='height:13.45pt'>
  <td width="34%" valign=top style='width:34.8%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:13.45pt'>
  <p class=MsoNormal style='line-height:normal'><span class=normaltextrun><span
  lang=EN-GB>Uncommon</span></span></p>
  </td>
  <td width="26%" valign=top style='width:26.52%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:13.45pt'>
  <p class=MsoNormal style='line-height:normal'><span class=normaltextrun><span
  lang=EN-GB>Injection site pruritus</span></span></p>
  </td>
 </tr>
 <tr style='height:13.0pt'>
  <td width="34%" valign=top style='width:34.8%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:13.0pt'>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Rare</span></p>
  </td>
  <td width="26%" valign=top style='width:26.52%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 0in 0in 0in;height:13.0pt'>
  <p class=MsoNormal style='line-height:normal'><span class=normaltextrun><span
  lang=EN-GB>Facial swelling*</span></span><span class=eop><span lang=EN-GB>**</span></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='font-size:9.0pt'>*Lymphadenopathy was captured as axillary
lymphadenopathy on the same side as the injection site. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='font-size:9.0pt'>**<span class=normaltextrun><span style='color:black;
background:white'>Throughout the safety follow-up period, acute peripheral
facial paralysis (or palsy) was reported by&#8239;three&#8239;participants in
the COVID-19 Vaccine Moderna group&#8239;and one participant in the placebo
group. Onset&#8239;in the vaccine group
participants&#8239;was&#8239;22&#8239;days,&#8239;28&#8239;days,
and&#8239;32&nbsp;days after Dose 2.</span></span><span class=eop><span
style='color:black;background:white'>&nbsp;</span></span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='font-size:9.0pt'>***There were two serious adverse events of facial
swelling in vaccine recipients with a history of injection of dermatological
fillers. The onset of swelling was reported 1 and 2 days, respectively, after
vaccination </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The reactogenicity
and safety profile in 343 subjects receiving COVID-19 Vaccine Moderna, that
were seropositive for SARS-CoV-2 at baseline, was comparable to that in subjects
seronegative for SARS-CoV-2 at baseline. </span></p>

<p class=MsoNormal style='text-align:justify;text-justify:inter-ideograph;
line-height:normal;text-autospace:none'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u><span
lang=EN-GB>Reporting of suspected adverse reactions</span></u></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>Reporting suspected adverse reactions after authorisation of the
medicinal product is important. It allows continued monitoring of the
benefit/risk balance of the medicinal product. Healthcare professionals are
asked to report any suspected adverse reactions via the national reporting
system listed in </span><span lang=EN-GB><a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a> and include batch/Lot number if available</span><span lang=EN-GB>.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.9     Overdose</span></b></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='color:black'>No case of overdose has been reported.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='color:black'>In the event of overdose, monitoring of vital
functions and possible symptomatic treatment is recommended.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>5.       PHARMACOLOGICAL
PROPERTIES</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>5.1     Pharmacodynamic properties</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Pharmacotherapeutic group: Vaccine, other
viral vaccines, ATC code: J07BX03</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u><span
lang=EN-GB>Mechanism of action</span></u></p>

<p class=MsoNormal><span lang=EN-GB>COVID-19 Vaccine Moderna contains mRNA
encapsulated in lipid nanoparticles. The mRNA encodes for the full-length
SARS-CoV-2 spike protein modified with 2 proline substitutions within the
heptad repeat 1 domain (S-2P) to stabilise the spike protein into a prefusion
conformation. After intramuscular injection, cells at the injection site and
the draining lymph nodes take up the lipid nanoparticle, effectively delivering
the mRNA sequence into cells for translation into viral protein. The delivered
mRNA does not enter the cellular nucleus or interact with the genome, is
non-replicating, and is expressed transiently mainly by dendritic cells and
subcapsular sinus macrophages. The expressed, membrane-bound spike protein of
SARS-CoV-2 is then recognised by immune cells as a foreign antigen. This
elicits both T-cell and B-cell responses to generate neutralising antibodies,
which may contribute to protection against COVID-19.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='background:yellow'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u><span
lang=EN-GB>Clinical efficacy</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The randomised,
placebo-controlled, observer-blind Phase 3 clinical study </span><span
lang=EN-GB>(NCT04470427) </span><span lang=EN-GB>excluded individuals who were
immunocompromised or had received immunosuppressants within 6 months, as well
as participants who were</span><span lang=EN-GB> pregnant, or with a known
history of SARS-CoV-2 infection</span><span lang=EN-GB>. Participants with
stable HIV disease were not excluded. Influenza vaccines could be administered
14 days before or 14 days after any dose of COVID-19 Vaccine Moderna. Participants
were also required to observe a minimum interval of 3 months after receipt of
blood/plasma products or immunoglobulins prior to the study in order to receive
either placebo or COVID-19 Vaccine Moderna.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>A total of 30,351
subjects were followed for a median of 92 days (range: 1-122) for the
development of COVID-19 disease. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>The primary efficacy analysis population
(referred to as the Per Protocol Set or PPS), included 28,207</span><span
lang=EN-GB style='font-family:"Arial",sans-serif'>&nbsp;</span><span
lang=EN-GB>subjects who received either COVID-19 Vaccine Moderna (n=14,134) or
placebo (n=14,073) and had a negative baseline SARS-CoV-2 status. The PPS study
population included 47.4% female, 52.6% male, 79.5% White, 9.7% African
American, 4.6% Asian, and 6.2% other. 19.7% of participants identified as Hispanic
or Latino. The median age of subjects was 53 years (range 18-94). A dosing window
of –7 to +14 days for administration of the second dose (scheduled at day 29) was
allowed for inclusion in the PPS. </span><span class=normaltextrun><span
lang=EN-GB style='color:black;background:white'> 98% of vaccine recipients
received the second dose 25 days to 35 days after dose 1 (corresponding to -3
to +7 days around the interval of 28 days).</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>COVID-19 cases
were confirmed by Reverse Transcriptase Polymerase Chain Reaction (RT PCR) and
by a Clinical Adjudication Committee.</span><span lang=EN-GB> </span><span
lang=EN-GB>Vaccine efficacy overall and by key age groups are presented in
Table 2.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Table&nbsp;2:&nbsp;Vaccine&nbsp;Efficacy&nbsp;Analysis:&nbsp;confirmed
COVID-19</span></b><b><sup><span lang=EN-GB># </span></sup></b><b><span
lang=EN-GB>regardless of severity starting 14 days after the 2<sup>nd</sup>&nbsp;dose&nbsp;–
Per-Protocol Set </span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%"
 style='width:100.0%;border-collapse:collapse;border:none'>
 <tr style='height:18.4pt'>
  <td width="14%" rowspan=2 style='width:14.22%;border:solid black 1.0pt;
  border-bottom:solid black 1.0pt;padding:0in 0in 0in 0in;height:18.4pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:5.35pt;
  margin-bottom:0in;margin-left:5.55pt;margin-bottom:.0001pt;text-align:center;
  line-height:normal;text-autospace:none'><b><span lang=EN-GB style='font-size:
  10.0pt'>Age Group (Years)</span></b></p>
  </td>
  <td width="34%" colspan=3 style='width:34.5%;border:solid black 1.0pt;
  border-left:none;padding:0in 0in 0in 0in;height:18.4pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal;
  text-autospace:none'><b><span lang=EN-GB style='font-size:10.0pt'>COVID-19
  Vaccine Moderna</span></b></p>
  </td>
  <td width="36%" colspan=3 style='width:36.48%;border:solid black 1.0pt;
  border-left:none;padding:0in 0in 0in 0in;height:18.4pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:64.1pt;
  margin-bottom:0in;margin-left:64.35pt;margin-bottom:.0001pt;text-align:center;
  line-height:normal;text-autospace:none'><b><span lang=EN-GB style='font-size:
  10.0pt'>Placebo</span></b></p>
  </td>
  <td width="14%" style='width:14.78%;border:solid black 1.0pt;border-left:
  none;padding:0in 0in 0in 0in;height:18.4pt'>
  <p class=MsoNormal align=center style='margin-left:.15pt;text-align:center;
  line-height:normal;text-autospace:none'><b><span lang=EN-GB style='font-size:
  10.0pt'>&nbsp;</span></b></p>
  </td>
 </tr>
 <tr style='height:49.0pt'>
  <td width="8%" style='width:8.88%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:49.0pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal;
  text-autospace:none'><b><span lang=EN-GB style='font-size:10.0pt'>Subjects</span></b></p>
  <p class=MsoNormal align=center style='margin-left:.25pt;text-align:center;
  line-height:normal;text-autospace:none'><b><span lang=EN-GB style='font-size:
  10.0pt'>N</span></b></p>
  </td>
  <td width="8%" style='width:8.88%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:49.0pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal;
  text-autospace:none'><b><span lang=EN-GB style='font-size:10.0pt'>COVID-19
  Cases</span></b></p>
  <p class=MsoNormal align=center style='margin-left:.1pt;text-align:center;
  line-height:normal;text-autospace:none'><b><span lang=EN-GB style='font-size:
  10.0pt'>n</span></b></p>
  </td>
  <td width="16%" style='width:16.76%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:49.0pt'>
  <p class=MsoNormal align=center style='margin-left:9.0pt;text-align:center;
  text-indent:2.25pt;line-height:normal;text-autospace:none'><b><span
  lang=EN-GB style='font-size:10.0pt'>Incidence Rate</span></b></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:.25pt;
  line-height:normal;text-autospace:none'><b><span lang=EN-GB style='font-size:
  10.0pt'>of COVID-19 per 1,000 Person-Years</span></b></p>
  </td>
  <td width="8%" style='width:8.88%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:49.0pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal;
  text-autospace:none'><b><span lang=EN-GB style='font-size:10.0pt'>Subjects</span></b></p>
  <p class=MsoNormal align=center style='margin-left:.15pt;text-align:center;
  line-height:normal;text-autospace:none'><b><span lang=EN-GB style='font-size:
  10.0pt'>N</span></b></p>
  </td>
  <td width="10%" style='width:10.84%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:49.0pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal;
  text-autospace:none'><b><span lang=EN-GB style='font-size:10.0pt'>COVID-19
  Cases</span></b></p>
  <p class=MsoNormal align=center style='margin-left:.3pt;text-align:center;
  line-height:normal;text-autospace:none'><b><span lang=EN-GB style='font-size:
  10.0pt'>n</span></b></p>
  </td>
  <td width="16%" style='width:16.76%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:49.0pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:4.35pt;
  margin-bottom:0in;margin-left:4.2pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-.3pt;line-height:normal;text-autospace:none'><b><span
  lang=EN-GB style='font-size:10.0pt'>Incidence Rate of COVID-19 per 1,000
  Person-Years</span></b></p>
  </td>
  <td width="14%" style='width:14.78%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:49.0pt'>
  <p class=MsoNormal align=center style='margin-bottom:8.0pt;text-align:center;
  line-height:normal'><b><span lang=EN-GB style='font-size:10.0pt'>% Vaccine
  Efficacy (95% CI)*</span></b></p>
  </td>
 </tr>
 <tr style='height:28.75pt'>
  <td width="14%" style='width:14.22%;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:28.75pt'>
  <p class=MsoNormal style='margin-left:5.35pt;line-height:12.2pt;text-autospace:
  none'><span lang=EN-GB style='font-size:10.0pt'>Overall</span></p>
  <p class=MsoNormal style='margin-left:5.35pt;line-height:14.7pt;text-autospace:
  none'><span lang=EN-GB style='font-size:10.0pt'>(</span><span
  style='font-size:10.0pt;font-family:Symbol'>³</span><span lang=EN-GB
  style='font-size:10.0pt'>18)</span></p>
  </td>
  <td width="8%" style='width:8.88%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.75pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:4.1pt;
  margin-bottom:0in;margin-left:4.45pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.2pt;text-autospace:none'><span lang=EN-GB style='font-size:
  10.0pt'>14,134</span></p>
  </td>
  <td width="8%" style='width:8.88%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.75pt'>
  <p class=MsoNormal align=center style='margin-left:.15pt;text-align:center;
  line-height:12.2pt;text-autospace:none'><span lang=EN-GB style='font-size:
  10.0pt'>11</span></p>
  </td>
  <td width="16%" style='width:16.76%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.75pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:10.45pt;
  margin-bottom:0in;margin-left:10.5pt;margin-bottom:.0001pt;text-align:center;
  line-height:106%;text-autospace:none'><span lang=EN-GB style='font-size:10.0pt;
  line-height:106%'>3.328</span></p>
  </td>
  <td width="8%" style='width:8.88%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.75pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:5.35pt;
  margin-bottom:0in;margin-left:5.6pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.2pt;text-autospace:none'><span lang=EN-GB style='font-size:
  10.0pt'>14,073</span></p>
  </td>
  <td width="10%" style='width:10.84%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.75pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:5.35pt;
  margin-bottom:0in;margin-left:5.7pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.2pt;text-autospace:none'><span lang=EN-GB style='font-size:
  10.0pt'>185</span></p>
  </td>
  <td width="16%" style='width:16.76%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.75pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:10.45pt;
  margin-bottom:0in;margin-left:10.5pt;margin-bottom:.0001pt;text-align:center;
  line-height:106%;text-autospace:none'><span lang=EN-GB style='font-size:10.0pt;
  line-height:106%'>56.510</span></p>
  </td>
  <td width="14%" style='width:14.78%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.75pt'>
  <p class=TableParagraph style='margin-right:-4.5pt;line-height:12.2pt'><span
  lang=EN-GB style='font-size:10.0pt'>94.1</span></p>
  <p class=MsoNormal align=center style='margin-right:-4.5pt;text-align:center;
  line-height:106%;text-autospace:none'><span lang=EN-GB style='font-size:10.0pt;
  line-height:106%'>(89.3, 96.8)**</span></p>
  </td>
 </tr>
 <tr style='height:27.9pt'>
  <td width="14%" style='width:14.22%;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:27.9pt'>
  <p class=MsoNormal style='margin-left:5.35pt;line-height:12.1pt;text-autospace:
  none'><span lang=EN-GB style='font-size:10.0pt'>18 to &lt;65</span></p>
  </td>
  <td width="8%" style='width:8.88%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:27.9pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:4.1pt;
  margin-bottom:0in;margin-left:4.45pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.1pt;text-autospace:none'><span lang=EN-GB style='font-size:
  10.0pt'>10,551</span></p>
  </td>
  <td width="8%" style='width:8.88%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:27.9pt'>
  <p class=MsoNormal align=center style='margin-left:.15pt;text-align:center;
  line-height:12.1pt;text-autospace:none'><span lang=EN-GB style='font-size:
  10.0pt'>7</span></p>
  </td>
  <td width="16%" style='width:16.76%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:27.9pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:10.45pt;
  margin-bottom:0in;margin-left:10.5pt;margin-bottom:.0001pt;text-align:center;
  line-height:106%;text-autospace:none'><span lang=EN-GB style='font-size:10.0pt;
  line-height:106%'>2.875</span></p>
  </td>
  <td width="8%" style='width:8.88%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:27.9pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:5.35pt;
  margin-bottom:0in;margin-left:5.6pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.1pt;text-autospace:none'><span lang=EN-GB style='font-size:
  10.0pt'>10,521</span></p>
  </td>
  <td width="10%" style='width:10.84%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:27.9pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:5.35pt;
  margin-bottom:0in;margin-left:5.7pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.1pt;text-autospace:none'><span lang=EN-GB style='font-size:
  10.0pt'>156</span></p>
  </td>
  <td width="16%" style='width:16.76%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:27.9pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:10.45pt;
  margin-bottom:0in;margin-left:10.5pt;margin-bottom:.0001pt;text-align:center;
  line-height:106%;text-autospace:none'><span lang=EN-GB style='font-size:10.0pt;
  line-height:106%'>64.625</span></p>
  </td>
  <td width="14%" style='width:14.78%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:27.9pt'>
  <p class=TableParagraph style='margin-right:-4.5pt;line-height:12.1pt'><span
  lang=EN-GB style='font-size:10.0pt'>95.6</span></p>
  <p class=MsoNormal align=center style='margin-right:-4.5pt;text-align:center;
  line-height:106%;text-autospace:none'><span lang=EN-GB style='font-size:10.0pt;
  line-height:106%'>(90.6, 97.9)</span></p>
  </td>
 </tr>
 <tr style='height:28.05pt'>
  <td width="14%" style='width:14.22%;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:28.05pt'>
  <p class=MsoNormal style='margin-left:5.35pt;line-height:12.2pt;text-autospace:
  none'><span style='font-size:10.0pt;font-family:Symbol'>³</span><span
  lang=EN-GB style='font-size:10.0pt'>65</span></p>
  </td>
  <td width="8%" style='width:8.88%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:4.1pt;
  margin-bottom:0in;margin-left:4.45pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.2pt;text-autospace:none'><span lang=EN-GB style='font-size:
  10.0pt'>3,583</span></p>
  </td>
  <td width="8%" style='width:8.88%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=MsoNormal align=center style='margin-left:.15pt;text-align:center;
  line-height:12.2pt;text-autospace:none'><span lang=EN-GB style='font-size:
  10.0pt'>4</span></p>
  </td>
  <td width="16%" style='width:16.76%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:10.45pt;
  margin-bottom:0in;margin-left:10.5pt;margin-bottom:.0001pt;text-align:center;
  line-height:106%;text-autospace:none'><span lang=EN-GB style='font-size:10.0pt;
  line-height:106%'>4.595</span></p>
  </td>
  <td width="8%" style='width:8.88%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:5.35pt;
  margin-bottom:0in;margin-left:5.6pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.2pt;text-autospace:none'><span lang=EN-GB style='font-size:
  10.0pt'>3,552</span></p>
  </td>
  <td width="10%" style='width:10.84%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:5.35pt;
  margin-bottom:0in;margin-left:5.7pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.2pt;text-autospace:none'><span lang=EN-GB style='font-size:
  10.0pt'>29</span></p>
  </td>
  <td width="16%" style='width:16.76%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:10.45pt;
  margin-bottom:0in;margin-left:10.5pt;margin-bottom:.0001pt;text-align:center;
  line-height:106%;text-autospace:none'><span lang=EN-GB style='font-size:10.0pt;
  line-height:106%'>33.728</span></p>
  </td>
  <td width="14%" style='width:14.78%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=TableParagraph style='margin-right:-4.5pt;line-height:106%'><span
  lang=EN-GB style='font-size:10.0pt;line-height:106%'>86.4</span></p>
  <p class=MsoNormal align=center style='margin-right:-4.5pt;text-align:center;
  line-height:106%;text-autospace:none'><span lang=EN-GB style='font-size:10.0pt;
  line-height:106%'>(61.4, 95.2)</span></p>
  </td>
 </tr>
 <tr style='height:28.05pt'>
  <td width="14%" style='width:14.22%;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:28.05pt'>
  <p class=MsoNormal style='margin-left:11.0pt;line-height:12.2pt;text-autospace:
  none'><span style='font-size:10.0pt;font-family:Symbol'>³65</span><span
  lang=EN-GB style='font-size:10.0pt'> to </span><span style='font-size:10.0pt;
  font-family:Symbol'>&lt;75</span></p>
  </td>
  <td width="8%" style='width:8.88%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:4.1pt;
  margin-bottom:0in;margin-left:4.45pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.2pt;text-autospace:none'><span lang=EN-GB style='font-size:
  10.0pt'>2,953</span></p>
  </td>
  <td width="8%" style='width:8.88%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=MsoNormal align=center style='margin-left:.15pt;text-align:center;
  line-height:12.2pt;text-autospace:none'><span lang=EN-GB style='font-size:
  10.0pt'>4</span></p>
  </td>
  <td width="16%" style='width:16.76%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:10.45pt;
  margin-bottom:0in;margin-left:10.5pt;margin-bottom:.0001pt;text-align:center;
  line-height:106%;text-autospace:none'><span lang=EN-GB style='font-size:10.0pt;
  line-height:106%'>5.586</span></p>
  </td>
  <td width="8%" style='width:8.88%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:5.35pt;
  margin-bottom:0in;margin-left:5.6pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.2pt;text-autospace:none'><span lang=EN-GB style='font-size:
  10.0pt'>2,864</span></p>
  </td>
  <td width="10%" style='width:10.84%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:5.35pt;
  margin-bottom:0in;margin-left:5.7pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.2pt;text-autospace:none'><span lang=EN-GB style='font-size:
  10.0pt'>22</span></p>
  </td>
  <td width="16%" style='width:16.76%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:10.45pt;
  margin-bottom:0in;margin-left:10.5pt;margin-bottom:.0001pt;text-align:center;
  line-height:106%;text-autospace:none'><span lang=EN-GB style='font-size:10.0pt;
  line-height:106%'>31.744</span></p>
  </td>
  <td width="14%" style='width:14.78%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=TableParagraph style='margin-right:-4.5pt;line-height:106%'><span
  lang=EN-GB style='font-size:10.0pt;line-height:106%'>82.4%</span></p>
  <p class=TableParagraph style='margin-right:-4.5pt;line-height:106%'><span
  lang=EN-GB style='font-size:10.0pt;line-height:106%'>(48.9, 93.9)</span></p>
  </td>
 </tr>
 <tr style='height:28.05pt'>
  <td width="14%" style='width:14.22%;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:28.05pt'>
  <p class=MsoNormal style='margin-left:11.0pt;line-height:12.2pt;text-autospace:
  none'><span style='font-size:10.0pt;font-family:Symbol'>³75</span></p>
  </td>
  <td width="8%" style='width:8.88%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:4.1pt;
  margin-bottom:0in;margin-left:4.45pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.2pt;text-autospace:none'><span lang=EN-GB style='font-size:
  10.0pt'>630</span></p>
  </td>
  <td width="8%" style='width:8.88%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=MsoNormal align=center style='margin-left:.15pt;text-align:center;
  line-height:12.2pt;text-autospace:none'><span lang=EN-GB style='font-size:
  10.0pt'>0</span></p>
  </td>
  <td width="16%" style='width:16.76%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:10.45pt;
  margin-bottom:0in;margin-left:10.5pt;margin-bottom:.0001pt;text-align:center;
  line-height:106%;text-autospace:none'><span lang=EN-GB style='font-size:10.0pt;
  line-height:106%'>0</span></p>
  </td>
  <td width="8%" style='width:8.88%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:5.35pt;
  margin-bottom:0in;margin-left:5.6pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.2pt;text-autospace:none'><span lang=EN-GB style='font-size:
  10.0pt'>688</span></p>
  </td>
  <td width="10%" style='width:10.84%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:5.35pt;
  margin-bottom:0in;margin-left:5.7pt;margin-bottom:.0001pt;text-align:center;
  line-height:12.2pt;text-autospace:none'><span lang=EN-GB style='font-size:
  10.0pt'>7</span></p>
  </td>
  <td width="16%" style='width:16.76%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=MsoNormal align=center style='margin-top:0in;margin-right:10.45pt;
  margin-bottom:0in;margin-left:10.5pt;margin-bottom:.0001pt;text-align:center;
  line-height:106%;text-autospace:none'><span lang=EN-GB style='font-size:10.0pt;
  line-height:106%'>41.968</span></p>
  </td>
  <td width="14%" style='width:14.78%;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:28.05pt'>
  <p class=TableParagraph style='margin-right:-4.5pt;line-height:106%'><span
  lang=EN-GB style='font-size:10.0pt;line-height:106%'>100%</span></p>
  <p class=TableParagraph style='margin-right:-4.5pt;line-height:106%'><span
  lang=EN-GB style='font-size:10.0pt;line-height:106%'>(NE, 100)</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='line-height:normal'><sup><span lang=EN-GB
style='font-size:10.0pt;color:white'>#</span></sup><span lang=EN-GB
style='font-size:10.0pt'>COVID-19: symptomatic COVID-19 requiring positive
RT-PCR result and at least 2 systemic symptoms or 1 respiratory&nbsp;symptom.&nbsp;Cases&nbsp;starting
14 days after the 2<sup>nd</sup>&nbsp;dose.&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='font-size:10.0pt'>*Vaccine efficacy and 95% confidence interval (CI)
from the stratified Cox proportional hazard model</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='font-size:10.0pt'>** CI not adjusted for multiplicity. Multiplicity
adjusted statistical analyses were carried out in an interim analysis based on
less COVID-19 cases, not reported here.</span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Among all
subjects in the PPS, no cases of severe COVID-19 were reported in the vaccine
group compared with 30 of 185 (16%) cases reported in the placebo group.</span><span
lang=EN-GB> Of the 30 participants with severe disease, 9 were hospitalised, 2
of which were </span><span lang=EN-GB>admitted to an intensive care unit. The
majority of the remaining severe cases fulfilled only the oxygen saturation
(SpO2) criterion for severe disease (&#8804; 93% on room air). </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The vaccine
efficacy of COVID-19 Vaccine Moderna to prevent COVID-19, regardless of prior
SARS-CoV-2 infection (determined by baseline serology and nasopharyngeal swab
sample testing) from 14 days after Dose 2 was 93.6% (95% confidence interval
88.5, 96.4%). </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Additionally,
subgroup analyses of the primary efficacy endpoint showed similar efficacy
point estimates across genders, ethnic groups, and participants with medical
comorbidities associated with high risk of severe COVID-19.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='font-size:12.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><u><span
lang=EN-GB>Elderly population </span></u></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>COVID-19 Vaccine Moderna was assessed in individuals 18 years of age
and older, including 3,768 subjects 65 years of age and older. The efficacy of
COVID-19 Vaccine Moderna was consistent between elderly (&#8805;65 years) and
younger adult subjects (18-64 years). </span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB style='background:yellow'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><u><span
lang=EN-GB>Paediatric population</span></u></p>

<p class=MsoNormal style='page-break-after:avoid'><span lang=EN-GB>The European
Medicines Agency has deferred the obligation to submit the results of studies
with the COVID-19 Vaccine</span><span lang=EN-GB> Moderna </span><span
lang=EN-GB>in one or more subsets of the paediatric population in </span><span
lang=EN-GB>prevention of COVID-19 </span><span lang=EN-GB>(see section 4.2 for
information on paediatric use).</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB>Conditional Approval</span></u></p>

<p class=MsoNormal><span lang=EN-GB>This medicinal product has been authorised
under a so-called ‘conditional approval’ scheme. This means that further
evidence on this medicinal product is awaited. The European Medicines Agency
will review new information on this medicinal product at least every year and
this SmPC will be updated as necessary.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>5.2     Pharmacokinetic properties</span></b></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Not applicable.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>5.3     Preclinical safety data</span></b></p>

<p class=MsoNormal><span lang=EN-GB>Non-clinical data reveal no special hazard
for humans based on conventional studies of repeat dose toxicity and
reproductive and developmental toxicity.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB>General Toxicity:</span></u></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>General toxicity studies were conducted in rats (intramuscularly
receiving up to 4 doses exceeding the human dose once every 2 weeks). </span><span
lang=EN-GB>Transient and reversible injection site oedema and erythema and </span><span
lang=EN-GB>transient and reversible changes in laboratory tests (including increases
in eosinophils, activated partial thromboplastin time, and fibrinogen) were
observed. Results suggests the toxicity potential to humans is low.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB>Genotoxicity/Carcinogenicity:</span></u></p>

<p class=MsoNormal><span lang=EN-GB>In vitro and in vivo genotoxicity studies were
conducted with the novel lipid component SM-102 of the vaccine. Results
suggests the genotoxicity potential to humans is very low. Carcinogenicity
studies were not performed.</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB>Reproductive Toxicity:</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In&nbsp;a&nbsp;developmental
toxicity study,&nbsp;0.2 mL of a vaccine formulation&nbsp;containing&nbsp;the
same quantity of mRNA (100 micrograms) and other ingredients&nbsp;included in a
single human dose&nbsp;of COVID-19 Vaccine&nbsp;Moderna was administered
to&nbsp;female rats&nbsp;by the intramuscular route on four occasions: 28 and
14 days prior to mating, and on gestation days 1 and 13. SARS-CoV-2 antibody
responses were present in maternal animals from prior to mating to the end of
the study on lactation day 21 as well as in foetuses and offspring. There were
no vaccine-related&nbsp;adverse effects on&nbsp;female fertility,&nbsp;pregnancy,
embryo foetal&nbsp;or offspring development or&nbsp;postnatal development. No
data are available of mRNA-1273 vaccine placental transfer or excretion in
milk.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.       PHARMACEUTICAL
PARTICULARS</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.1     List of excipients</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Lipid SM-102 </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Cholesterol </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>1,2-distearoyl-sn-glycero-3-phosphocholine
(DSPC)</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>1,2-Dimyristoyl-rac-glycero-3-methoxypolyethylene
glycol-2000 (PEG2000 DMG)</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tromethamol</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tromethamol hydrochloride</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Acetic acid </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Sodium acetate
trihydrate </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Sucrose </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Water for
injections</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.2     Incompatibilities</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>This medicinal
product must not be mixed with other medicinal products or diluted. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.3     Shelf life</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Unopened
vial:</span></u><span lang=EN-GB> </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>7 months at </span><span
lang=EN-GB>-25ºC to -15ºC.</span></p>

<p class=MsoNormal style='line-height:normal'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The unopened
vaccine may be stored refrigerated at 2°C to 8°C, protected from light, for maximum
30 days</span><span lang=EN-GB>.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Once thawed the
vaccine should not be re-frozen.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The unopened
vaccine may be stored at 8°C to 25°C up to 12 hours after removal from
refrigerated conditions. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><u><span lang=EN-GB>Punctured
Vial: </span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Chemical and
physical in-use stability has been demonstrated for 6 hours at 2°C to 25ºC
after initial puncture. From a microbiological point of view, the product
should be used immediately. If the vaccine is not used immediately, in-use
storage times and conditions are the responsibility of the user</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>6.4     Special precautions
for storage</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Store in a
freezer frozen between -25ºC to -15ºC.</span></p>

<p class=MsoNormal><span lang=EN-GB>Store in the </span><span
class=BodytextAgencyChar><span lang=EN-GB style='font-family:"Times New Roman",serif'>original</span></span><span
lang=EN-GB> carton to protect from light.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not store on
dry ice or below -40ºC.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>For storage
conditions after thawing and first opening see section 6.3.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>6.5     Nature and contents of container </span></b></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>5 ml dispersion in a vial (type 1 or type 1 equivalent glass) with a
stopper (chlorobutyl rubber) and a flip-off plastic cap with seal (aluminium
seal). </span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>Each vial contains 10 doses of 0.5mL. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Pack size: 10
multidose vials</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><a name="OLE_LINK1"><b><span lang=EN-GB>6.6</span></b></a><b><span
lang=EN-GB>     </span><span lang=EN-GB>Special precautions for disposal and
other handling</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The vaccine
should be prepared and administered by a trained healthcare professional using
aseptic techniques to ensure sterility of the dispersion.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The vaccine
comes ready to use once thawed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not shake or
dilute. Swirl the vial gently after thawing and before each withdrawal.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>COVID-19 Vaccine
Moderna vials are multidose. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Ten (10) doses (of
0.5mL each) can be withdrawn from each vial.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>An additional
overfill is included in each vial to ensure that 10 doses of 0.5 mL can be
delivered.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE><img border=0
width=604 height=144 id="Picture 1775347031"
src="COVID-19%20Vaccine%20Moderna%205791%20-%20Product%20Information%20final_files/image003.png"></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE><img border=0
width=604 height=171
src="COVID-19%20Vaccine%20Moderna%205791%20-%20Product%20Information%20final_files/image004.png"></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE><img border=0
width=604 height=326
src="COVID-19%20Vaccine%20Moderna%205791%20-%20Product%20Information%20final_files/image005.png"></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE><img border=0
width=604 height=295
src="COVID-19%20Vaccine%20Moderna%205791%20-%20Product%20Information%20final_files/image006.png"></span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>7.       MARKETING AUTHORISATION HOLDER</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>MODERNA BIOTECH
SPAIN, S.L.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Calle Monte
Esquinza 30</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>28010 Madrid</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Spain</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>8.       MARKETING AUTHORISATION NUMBER(S) </span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>EU/1/20/1507/001</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;line-height:
normal;page-break-after:avoid'><b><span lang=EN-GB>9.      DATE OF FIRST
AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><i><span
lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>Date of first authorisation: </span><span lang=EN-GB>{DD month YYYY}</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>10.     DATE OF REVISION OF THE TEXT</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Detailed information on this medicinal product is available on the
website of the European Medicines Agency </span><span lang=EN-GB><a
href="http://www.ema.europa.eu">http://www.ema.europa.eu</a></span><span
lang=EN-GB>.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>ANNEX II</span></b></p>

<p class=MsoNormal style='margin-right:70.8pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:70.8pt;margin-bottom:
0in;margin-left:85.5pt;margin-bottom:.0001pt;text-indent:-.5in;line-height:
normal'><b><span lang=EN-GB>A.        MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE
AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:70.9pt;margin-bottom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.45pt;line-height:
normal'><b><span lang=EN-GB>B.        CONDITIONS OR RESTRICTIONS REGARDING
SUPPLY AND USE</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:77.95pt;margin-bottom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.45pt;line-height:
normal'><b><span lang=EN-GB>C.        OTHER CONDITIONS AND REQUIREMENTS OF THE
MARKETING AUTHORISATION</span></b></p>

<p class=MsoNormal style='margin-right:77.9pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:70.8pt;margin-bottom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt;line-height:
normal'><b><span lang=EN-GB>D.        <span style='text-transform:uppercase'>conditions
or restrictions with regard to the safe and effective use of the medicinal
product</span></span></b></p>

<p class=MsoNormal style='margin-right:70.8pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:70.8pt;margin-bottom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt;line-height:
normal'><b><span lang=EN-GB>E.        SPECIFIC OBLIGATION TO COMPLETE
POST-AUTHORISATION MEASURES FOR THE CONDITIONAL MARKETING AUTHORISATION</span></b></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-left:27.0pt;text-indent:-27.0pt;line-height:
normal'><b><span lang=EN-GB>A.</span></b><span lang=EN-GB>      <b>MANUFACTURER</b><b>
OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURER RESPONSIBLE FOR BATCH
RELEASE</b></span></p>

<p class=MsoNormal style='margin-right:70.8pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><a name="_Hlk60503282"><u><span lang=EN-GB>Name and address
of the manufacturer of the biological active substance</span></u></a></p>

<p class=MsoNormal style='margin-right:70.8pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>LONZA AG</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Lonzastrasse 2</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Visp 3930</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Switzerland</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB>Name and address of the manufacturer
responsible for batch release</span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=paragraph style='margin:0in;vertical-align:baseline'><span
lang=ES-TRAD style='font-size:11.0pt'>Rovi Pharma Industrial Services, S.A. </span></p>

<p class=paragraph style='margin:0in;vertical-align:baseline'><span
lang=ES-TRAD style='font-size:11.0pt'>Paseo de Europa, 50</span></p>

<p class=paragraph style='margin:0in;vertical-align:baseline'><span
lang=ES-TRAD style='font-size:11.0pt'>28703. San Sebastián de los Reyes</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Madrid, Spain</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><a name="OLE_LINK2"><span
lang=EN-GB>In view of the declared Public Health Emergency of International
Concern and in order to ensure early supply this medicinal product is subject
to a time-limited exemption allowing reliance on batch control testing
conducted in the registered site(s) that are located in a third country. This
exemption ceases to be valid on 31 January 2021. Implementation of EU based
batch control arrangements, including the necessary variations to the terms of
the marketing authorisation, has to be completed by 31 January 2021 at the
latest, in line with the agreed plan for this transfer of testing.</span></a></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>B.</span></b><span lang=EN-GB>      <b>CONDITIONS
OR RESTRICTIONS REGARDING SUPPLY AND USE </b></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Medicinal
product subject to medical prescription.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.05pt;line-height:normal'><b><span
lang=EN-GB>Official batch release</span></b></p>

<p class=MsoNormal style='margin-right:-.05pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.05pt;line-height:normal'><span
lang=EN-GB>In accordance with Article 114 of Directive 2001/83/EC, the official
batch release will be undertaken by a state laboratory or a laboratory
designated for that purpose.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>C.      OTHER CONDITIONS AND REQUIREMENTS OF THE
MARKETING AUTHORISATION</span></b></p>

<p class=MsoNormal style='margin-right:-.05pt;line-height:normal'><u><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='margin-right:-.05pt;line-height:normal'><b><span
lang=EN-GB>Periodic safety update reports (PSURs)</span></b></p>

<p class=MsoNormal style='margin-right:28.35pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:28.35pt;line-height:normal'><span
lang=EN-GB>The requirements for submission of PSURs for this medicinal product
are set out in the list of Union reference dates (EURD list) </span><span
lang=EN-GB>provided for under Article 107c(7) of Directive 2001/83/EC and any
subsequent updates published on the European medicines web-portal.</span></p>

<p class=MsoNormal style='margin-right:28.35pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The marketing
authorisation holder (MAH) shall submit the first PSUR for this product within
6&nbsp;months following authorisation. </span></p>

<p class=MsoNormal style='margin-right:-.05pt;line-height:normal'><u><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>D.      CONDITIONS OR RESTRICTIONS WITH REGARD TO
THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span></b></p>

<p class=MsoNormal style='margin-right:-.05pt;line-height:normal'><u><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='margin-right:-.05pt;line-height:normal'><b><span
lang=EN-GB>Risk management plan (RMP)</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.05pt;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:28.35pt;line-height:normal'><span
lang=EN-GB>The marketing</span><span lang=EN-GB> authorisation holder (MAH)
shall perform the required pharmacovigilance activities and interventions
detailed in the agreed RMP presented in Module 1.8.2 of the marketing
authorisation and any agreed subsequent updates of the RMP.</span></p>

<p class=MsoNormal style='margin-right:-.05pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.05pt;line-height:normal'><span
lang=EN-GB>An updated RMP should be submitted:</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.05pt;margin-bottom:
0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.25in;line-height:normal'><span
lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>At the request of the European Medicines Agency;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.05pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-10.35pt;line-height:
normal'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Whenever the risk management system is modified,
especially as the result of new information being received that may lead to a significant
change to the benefit/risk profile or as the result of an important
(pharmacovigilance or risk minimisation) milestone being reached.</span></p>

<p class=MsoNormal style='margin-right:-.05pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=NormalAgency><span lang=EN-GB style='font-size:11.0pt;font-family:
"Times New Roman",serif'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.05pt;margin-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>E.      SPECIFIC OBLIGATION TO COMPLETE
POST-AUTHORISATION MEASURES FOR THE CONDITIONAL MARKETING AUTHORISATION</span></b></p>

<p class=MsoNormal style='margin-right:-.05pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.05pt;line-height:normal'><span
lang=EN-GB>This being a conditional marketing authorisation and pursuant to
Article 14-a of Regulation (EC) No 726/2004, the MAH shall complete, within the
stated timeframe, the following measures:</span></p>

<p class=MsoNormal style='margin-right:-.05pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="98%"
 style='border-collapse:collapse;border:none'>
 <thead>
  <tr>
   <td width="76%" valign=top style='width:76.4%;border:solid windowtext 1.0pt;
   padding:0in 5.4pt 0in 5.4pt'>
   <p class=MsoNormal style='margin-right:-.05pt;line-height:normal'><b><span
   lang=EN-GB>Description</span></b></p>
   </td>
   <td width="23%" valign=top style='width:23.6%;border:solid windowtext 1.0pt;
   border-left:none;padding:0in 5.4pt 0in 5.4pt'>
   <p class=MsoNormal style='margin-right:-.05pt;line-height:normal'><b><span
   lang=EN-GB>Due date</span></b></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td width="76%" valign=top style='width:76.4%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=TabletextrowsAgency style='line-height:normal'><span lang=EN-GB
  style='font-size:11.0pt;font-family:"Times New Roman",serif'>In order to
  complete the characterisation of the active substance and finished product
  manufacturing processes, the MAH should provide additional data.</span></p>
  <p class=TabletextrowsAgency style='line-height:normal'><span lang=EN-GB
  style='font-size:11.0pt;font-family:"Times New Roman",serif'>&nbsp;</span></p>
  </td>
  <td width="23%" valign=top style='width:23.6%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=TabletextrowsAgency style='line-height:normal'><span lang=EN-GB
  style='font-size:11.0pt;font-family:"Times New Roman",serif'>January 2021</span></p>
  </td>
 </tr>
 <tr>
  <td width="76%" valign=top style='width:76.4%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=TabletextrowsAgency style='line-height:normal'><span lang=EN-GB
  style='font-size:11.0pt;font-family:"Times New Roman",serif'>In order to
  confirm the consistency of the active substance and finished product
  manufacturing process (Initial and final scales), the MAH should provide
  additional comparability and validation data.</span></p>
  </td>
  <td width="23%" valign=top style='width:23.6%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=BodytextAgency><span lang=EN-GB style='font-size:11.0pt;font-family:
  "Times New Roman",serif'>April 2021</span></p>
  <p class=TabletextrowsAgency style='line-height:normal'><span lang=EN-GB
  style='font-size:11.0pt;font-family:"Times New Roman",serif'>Interim reports
  will be provided monthly prior to this date.</span></p>
  <p class=TabletextrowsAgency style='line-height:normal'><span lang=EN-GB
  style='font-size:11.0pt;font-family:"Times New Roman",serif'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width="76%" valign=top style='width:76.4%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=TabletextrowsAgency style='line-height:normal'><span lang=EN-GB
  style='font-size:11.0pt;font-family:"Times New Roman",serif'>In order to
  ensure consistent product quality, the MAH should provide additional
  information on stability of the active substance&nbsp;and finished product
  and review the active substance and finished product specifications following
  further manufacturing experience.&nbsp;</span></p>
  <p class=TabletextrowsAgency style='line-height:normal'><span lang=EN-GB
  style='font-size:11.0pt;font-family:"Times New Roman",serif'>&nbsp;</span></p>
  </td>
  <td width="23%" valign=top style='width:23.6%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=TabletextrowsAgency style='line-height:normal'><span lang=EN-GB
  style='font-size:11.0pt;font-family:"Times New Roman",serif'>June 2021</span></p>
  </td>
 </tr>
 <tr>
  <td width="76%" valign=top style='width:76.4%;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=TabletextrowsAgency style='line-height:normal'><span lang=EN-GB
  style='font-size:11.0pt;font-family:"Times New Roman",serif'>In order to
  confirm the efficacy and safety of COVID-19 Vaccine Moderna, the MAH should
  submit the final Clinical Study Report for the randomised,
  placebo-controlled, observer-blind study mRNA-1273-P301.</span></p>
  <p class=TabletextrowsAgency style='line-height:normal'><span lang=EN-GB
  style='font-size:11.0pt;font-family:"Times New Roman",serif'>&nbsp;</span></p>
  </td>
  <td width="23%" valign=top style='width:23.6%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=TabletextrowsAgency style='line-height:normal'><span lang=EN-GB
  style='font-size:11.0pt;font-family:"Times New Roman",serif'>December 2022</span></p>
  </td>
 </tr>
</table>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal style='margin-right:28.3pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>ANNEX III</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB>LABELLING
AND PACKAGE LEAFLET</span></b></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>A. LABELLING</span></b></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='line-height:normal;background:white'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;border:none;padding:0in'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>OUTER CARTON</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB>1.       NAME OF THE
MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>COVID-19 Vaccine
Moderna dispersion for injection</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>COVID-19 mRNA Vaccine
(nucleoside modified)</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB>2.       STATEMENT OF
ACTIVE SUBSTANCE(S)</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal;page-break-after:
avoid'><span lang=EN-GB>Each multidose vial contains 10 doses (0.5&nbsp;mL
each)</span><span lang=EN-GB>.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB>3.       LIST OF EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Excipients: Lipid
SM-102, cholesterol, 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), 1,2-Dimyristoyl-rac-glycero-3-methoxypolyethylene
glycol-2000 (PEG2000 DMG), tromethamol, tromethamol hydrochloride, acetic acid,
sodium acetate trihydrate, sucrose, water for injections.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB>4.       PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:lightgrey'>Dispersion for injection</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>10 multidose
vials </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB>5.       METHOD AND
ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Intramuscular
use.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Read the package
leaflet before use.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=paragraph style='margin-top:0in;margin-right:-.75pt;margin-bottom:
0in;margin-left:0in;vertical-align:baseline'><span lang=DE><img border=0
width=105 height=105 id="Picture 4"
src="COVID-19%20Vaccine%20Moderna%205791%20-%20Product%20Information%20final_files/image007.jpg"></span><span
class=eop><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Scan here for
package leaflet or visit</span><span lang=EN-GB> <a
href="http://www.modernacovid19global.com">www.modernacovid19global.com</a>.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB>6.       SPECIAL WARNING
THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='background:lightgrey'>Keep out of
sight and reach of children.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB>7.       OTHER SPECIAL
WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB>8.       EXPIRY DATE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EXP</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;page-break-after:avoid;border:none;padding:0in'><b><span lang=EN-GB>9.       SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>Store frozen at -25°C to -15°C.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>Read the package leaflet for the shelf life after
first opening and for additional storage information.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>Keep the vial in the outer carton to protect from
light</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal;border:none;padding:0in'><b><span lang=EN-GB>10.     SPECIAL PRECAUTIONS
FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH
MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:lightgrey'>Dispose of in accordance with local requirement.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>11.     NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=SV>MODERNA BIOTECH
SPAIN, S.L. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Calle Monte
Esquinza, 30</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>28010 Madrid </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Spain<i> </i></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>12.     MARKETING AUTHORISATION NUMBER(S) </span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EU/1/20/1507/001
</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>13.     BATCH NUMBER</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>14.     GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><i><span lang=EN-GB>&nbsp;</span></i></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>15.     INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>16.     INFORMATION IN BRAILLE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='color:black;background:#CCCCCC'>Justification for not including Braille
accepted.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:#CCCCCC'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:#CCCCCC'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>17.       UNIQUE IDENTIFIER – 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:lightgrey'>2D barcode carrying the unique identifier
included.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='display:none'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>18.       UNIQUE IDENTIFIER – HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>PC </span></p>

<p class=MsoNormal><span lang=EN-GB>SN </span></p>

<p class=MsoNormal><span lang=EN-GB>NN </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;background:#CCCCCC'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS</span></b></p>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>VIAL LABEL </span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>1.       NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF
ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>COVID-19 Vaccine
Moderna dispersion for injection</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>COVID-19 mRNA Vaccine
</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>IM</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>2.       METHOD OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB
style='background:lightgrey'>Intramuscular use</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>3.       EXPIRY DATE</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>EXP</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>4.       BATCH NUMBER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>Lot</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>5.       CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT</span></b></p>

</div>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>Multidose vial</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>(10 doses of 0.5 mL)</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN-GB>6.       OTHER</span></b></p>

</div>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=paragraph style='margin-top:0in;margin-right:-.75pt;margin-bottom:
0in;margin-left:0in;vertical-align:baseline'><span lang=DE><img border=0
width=109 height=109 id="Picture 6"
src="COVID-19%20Vaccine%20Moderna%205791%20-%20Product%20Information%20final_files/image008.jpg"></span><span
class=eop><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Scan here for
package leaflet or visit</span><span lang=EN-GB> <a
href="http://www.modernacovid19global.com">www.modernacovid19global.com</a>.</span></p>

<p class=MsoNormal style='margin-right:5.65pt;line-height:normal'><span
lang=EN-GB>Discard date/time:</span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>ANNEX III</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>PACKAGE LEAFLET</span></b></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>Package leaflet: Information for the user</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal;
background:white'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><b><span
lang=EN-GB>COVID-19 Vaccine Moderna dispersion for injection</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
lang=EN-GB>COVID-19 mRNA Vaccine (nucleoside modified)</span><img width=22
height=14
src="COVID-19%20Vaccine%20Moderna%205791%20-%20Product%20Information%20final_files/image009.png"
align=left hspace=12 vspace=5 alt=" "></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:0in;line-height:normal'><span
lang=EN-GB>This medicine is subject to additional monitoring. This will allow
quick identification of new safety information. You can help by reporting any
side effects you may get. See the end of section 4 for how to report side
effects.</span></p>

<p class=MsoListParagraphCxSpLast style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Read all of
this leaflet carefully before you receive this vaccine because it contains
important information for you.</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Keep this leaflet. You may need to read it
again. </span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you have any further questions, ask your
doctor, pharmacist or nurse.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-        If you get any side effects, talk to your
doctor, pharmacist or nurse.</span><span lang=EN-GB style='color:red'> </span><span
lang=EN-GB>This includes any possible side effects not listed in this leaflet.
See section 4.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What is in this leaflet</span></b></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>1.    What COVID-19 Vaccine Moderna is and what it is used for </span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>2.    What you need to know before you are given COVID-19 Vaccine
Moderna </span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>3.    How COVID-19 Vaccine</span><span lang=EN-GB> </span><span
lang=EN-GB>Moderna is given</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>4.    Possible side effects </span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>5.    How to store COVID-19 Vaccine</span><span lang=EN-GB> </span><span
lang=EN-GB>Moderna</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>6.    Contents of the pack and other information</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>1.</span></b><b><span lang=EN-GB>       What COVID-19 Vaccine</span></b><span
lang=EN-GB> </span><b><span lang=EN-GB>Moderna is and what it is used for</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span class=normaltextrun><span
lang=EN-GB style='color:black;background:white'>COVID-19
Vaccine&nbsp;Moderna&nbsp;is a vaccine used
to&nbsp;prevent&nbsp;COVID-19&nbsp;caused by&nbsp;SARS-CoV-2&nbsp;.&nbsp;It is
given to&nbsp;adults&nbsp;aged 18&nbsp;years&nbsp;and older.&nbsp;The active
substance in COVID-19 Vaccine Moderna is mRNA encoding the SARS-CoV-2 Spike protein.
The mRNA is embedded in SM-102 lipid nanoparticles.</span></span></p>

<p class=MsoNormal style='line-height:normal'><span class=normaltextrun><span
lang=EN-GB style='color:black;background:white'>&nbsp;</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>As </span><span
class=normaltextrun><span lang=EN-GB style='color:black;background:white'>COVID-19
Vaccine&nbsp;Moderna</span></span><span lang=EN-GB> does not contain the virus,
it cannot give you COVID-19.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>How the vaccine works </span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>COVID-19 Vaccine Moderna stimulates the body’s natural defences
(immune system). The vaccine works by causing the body to produce protection
(antibodies) against the virus that causes COVID-19. COVID-19 Vaccine Moderna uses
a substance called messenger ribonucleic acid (mRNA) to carry instructions that
cells in the body can use to make the spike protein that is also on the virus.
The cells then make antibodies against the spike protein to help fight off the
virus. This will help to protect you against COVID-19. </span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>2.       What you need to know before you are given COVID-19 Vaccine</span></b><span
lang=EN-GB> </span><b><span lang=EN-GB>Moderna</span></b></p>

<p class=MsoNormal><em><span lang=EN-GB>&nbsp;</span></em></p>

<p class=MsoNormal><b><span lang=EN-GB>The vaccine must not be given if </span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>-</span><span lang=EN-GB>        </span><span
lang=EN-GB>you are <b>allergic</b> to the active substance or any of the other
ingredients of this vaccine (listed in section 6).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Warnings and precautions </span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Talk to your
doctor, pharmacist or nurse before you are given COVID-19 Vaccine Moderna if: </span></p>

<p class=MsoListParagraphCxSpFirst style='margin-top:0in;margin-right:-.1pt;
margin-bottom:0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>you have previously had a severe,
life-threatening <b>allergic</b> reaction</span><span lang=EN-GB> after any
other vaccine</span></p>

<p class=MsoListParagraphCxSpFirst style='margin-top:0in;margin-right:-.1pt;
margin-bottom:0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in'><span
lang=EN-GB>-</span><span lang=EN-GB>injection or after you were given COVID-19
Vaccine Moderna in the past. </span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:-.1pt;
margin-bottom:0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>you have a very weak or compromised immune
system</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:-.1pt;
margin-bottom:0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>you have ever fainted following any needle
injection.</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:-.1pt;
margin-bottom:0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>you have a bleeding disorder&nbsp;</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:-.1pt;
margin-bottom:0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>you have a high fever or severe infection; </span><span
lang=EN-GB>however, you can have your vaccination if you have a mild fever or
upper airway infection like a cold</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:-.1pt;
margin-bottom:0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>you have any serious illness&nbsp;</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:-.1pt;
margin-bottom:0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>if you have anxiety related to injections</span></p>

<p class=MsoListParagraphCxSpLast style='margin-top:0in;margin-right:-.1pt;
margin-bottom:0in;margin-left:.25in;margin-bottom:.0001pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>If any of the above apply to you (or you are not sure), talk to your
doctor, pharmacist or</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>nurse before you are given COVID-19 Vaccine Moderna.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>As with any vaccine, the 2-dose vaccination course of COVID-19
Vaccine Moderna may not fully protect all those who receive it and it is not
known how long you will be protected’</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Children and adolescents</span></b></p>

<p class=MsoNormal style='text-autospace:none'><a name="_Hlk53493754"><span
lang=EN-GB>COVID-19 Vaccine Moderna is not recommended for children aged under
18 years.</span></a></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>Other medicines and COVID-19 Vaccine</span></b><span lang=EN-GB> </span><b><span
lang=EN-GB>Moderna</span></b></p>

<p class=MsoNormal><span lang=EN-GB>Tell your doctor or pharmacist if you are
taking, have recently taken, or might take any other medicines. COVID-19
Vaccine Moderna may affect the way other medicines work, and other medicines
may affect how COVID-19 Vaccine Moderna works.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Pregnancy and breast-feeding </span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>If you are
pregnant or breast-feeding, think you may be pregnant or are planning to have a
baby, tell your doctor, pharmacist or nurse before being vaccinated. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Driving and using machines</span></b></p>

<p class=MsoNormal><span lang=EN-GB>Do not drive or use machines if you are
feeling unwell after vaccination. Wait until any effects of the vaccine have
worn off before you drive or use machines. </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='page-break-after:avoid'><b><span lang=EN-GB>COVID-19
Vaccine Moderna contains sodium</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>COVID-19 Vaccine Moderna contains less than 1 mmol (23 mg) sodium
per dose and, that is to say, essentially ‘sodium-free’.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>3.       How you will be given </span></b><b><span lang=EN-GB>COVID-19
Vaccine</span></b><span lang=EN-GB> </span><b><span lang=EN-GB>Moderna</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>COVID-19 Vaccine Moderna will be given to you as two 0.5 mL
injections. </span><span class=normaltextrun><span lang=EN-GB style='color:
black;background:white'>It is recommended to administer the second dose of the
same vaccine 28 days after the first dose&nbsp;to complete the vaccination
course.</span></span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>Your doctor, pharmacist or nurse will inject the vaccine into a
muscle (intramuscular injection) in your upper arm.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>During and after each injection of the vaccine, your doctor,
pharmacist or nurse will watch over you for around 15 minutes to monitor for
signs of an allergic reaction.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><b><span
lang=EN-GB>If you miss an appointment for your 2<sup>nd</sup> dose of COVID-19
Vaccine</span></b><span lang=EN-GB> <b>Moderna</b></span></p>

<p class=MsoListParagraphCxSpFirst style='margin-top:0in;margin-right:-1.45pt;
margin-bottom:0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in;
line-height:normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you miss an appointment, arrange another
visit as soon as possible with you doctor, nurse, or pharmacist.</span></p>

<p class=MsoListParagraphCxSpLast style='margin-top:0in;margin-right:-1.45pt;
margin-bottom:0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in;
line-height:normal'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>If you miss a scheduled injection, you may not
be fully protected against COVID-19.</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>If you have any further questions on the use of this vaccine, ask
your doctor, pharmacist or nurse.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>4.       Possible side effects</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>Like all medicines, this vaccine can cause side effects, although
not everybody gets them.</span></p>

<p class=MsoNormal style='margin-right:-1.45pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Get <b><u>urgent</u></b> medical attention
if you get any of the following signs and symptoms of an allergic reaction: </span></p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-.25in'><span lang=EN-GB>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>feeling faint or light-headed;</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>changes in your heartbeat;</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>shortness of breath;</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>wheezing;</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>swelling of your lips, face, or throat;</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>hives or rash;</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>nausea or vomiting;</span></p>

<p class=MsoListParagraphCxSpLast style='text-indent:-.25in'><span lang=EN-GB>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>stomach pain.</span></p>

<p class=MsoNormal><span lang=EN-GB style='background:yellow'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Talk to your doctor or nurse if you develop
any other side effects. These can include:</span></p>

<p class=MsoNormal><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>Very common</span></b><span lang=EN-GB>
(may affect more than 1 in 10 people): </span></p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-.25in'><span lang=EN-GB>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>swelling in the underarm</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>headache </span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>nausea</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>vomiting</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>muscle ache, joint aches, and stiffness </span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>pain or swelling at the injection site</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>feeling very tired</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>chills </span></p>

<p class=MsoListParagraphCxSpLast style='text-indent:-.25in'><span lang=EN-GB>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>fever </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Common </span></b><span lang=EN-GB>(may
affect up to 1 in 10 people):</span></p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-.25in'><span lang=EN-GB>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>rash</span></p>

<p class=MsoListParagraphCxSpLast style='text-indent:-.25in'><span lang=EN-GB>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>rash, redness, or hives at the injection site </span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Uncommon </span></b><span lang=EN-GB>(may
affect up to 1 in 100 people):</span></p>

<p class=MsoListParagraph style='text-indent:-.25in'><span lang=EN-GB>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>itchiness at the injection site</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>Rare</span></b><span lang=EN-GB>&nbsp;(may
affect up to 1 in 1000&nbsp;people)&nbsp;</span></p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-.25in;line-height:normal'><span
lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>temporary one-sided facial drooping (Bell’s
palsy)</span></p>

<p class=MsoListParagraphCxSpLast style='text-indent:-.25in'><span lang=EN-GB>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>swelling of the face&nbsp;(Swelling of the face may occur in
patients who have had facial cosmetic injections.)</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Frequency unknown</span></b><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-.25in'><span lang=EN-GB>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>severe allergic reactions (Anaphylaxis)&nbsp;</span></p>

<p class=MsoListParagraphCxSpLast style='text-indent:-.25in'><span lang=EN-GB>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB>hypersensitivity</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB>Reporting of side effects</span></b></p>

<p class=MsoNormal><span lang=EN-GB>If you get any side effects, talk to your
doctor, pharmacist or nurse.</span><span lang=EN-GB style='color:red'> </span><span
lang=EN-GB>This includes any possible side effects not listed in this leaflet.
You can also report side effects directly via the national reporting system
listed in </span><span class=MsoHyperlink><span lang=EN-GB>Appendix V</span></span><span
lang=EN-GB>. By reporting side effects you can help provide more information on
the safety of this vaccine.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><b><span lang=EN-GB>5.</span></b><b><span lang=EN-GB>       </span><span
lang=EN-GB>How to store COVID-19 Vaccine</span></b><span lang=EN-GB> <b>Moderna</b></span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Keep this vaccine out of the sight and reach of children.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not use this vaccine after the expiry date which is stated on the
label after EXP. The expiry date refers to the last day of that month.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Information about storage, expiry, and use and handling are
described in the section intended for</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>healthcare professionals at the end of the package leaflet.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Do not throw away any medicines via wastewater or household waste.
Ask your pharmacist how to throw away medicines you no longer use. These
measures will help protect the environment.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal;page-break-after:
avoid'><b><span lang=EN-GB>6.       Contents of the pack and other information</span></b></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal;page-break-after:
avoid'><b><span lang=EN-GB>What COVID-19 Vaccine Moderna contains </span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal;page-break-after:
avoid'><b><span lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoListParagraphCxSpFirst style='margin-top:0in;margin-right:-.1pt;
margin-bottom:0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in;
line-height:normal;page-break-after:avoid'><span lang=EN-GB>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span class=normaltextrun><span lang=EN-GB>This is a multidose
vial&nbsp;which contains 10&nbsp;doses of 0.5&nbsp;mL.</span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.25in;text-indent:-.25in;
line-height:normal;page-break-after:avoid'><span lang=EN-GB>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span class=normaltextrun><span lang=EN-GB>One dose (0.5 mL) contains&nbsp;100&nbsp;micrograms&nbsp;of&nbsp;messenger&nbsp;RNA&nbsp;(mRNA)
(embedded in SM-102 lipid nanoparticles).</span></span><span class=eop>&nbsp;</span></p>

<p class=MsoListParagraphCxSpLast style='margin-left:.25in;text-indent:-.25in;
line-height:normal;page-break-after:avoid'><span lang=EN-GB>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span class=normaltextrun><span lang=EN-GB>Single-stranded,
5’-capped messenger RNA (mRNA) produced using a cell-free in vitro
transcription from the corresponding DNA templates, encoding the viral spike
(S) protein of SARS-CoV-2.</span></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in;line-height:normal;
page-break-after:avoid'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The other ingredients are lipid SM-102,
cholesterol, 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), 1,2-Dimyristoyl-rac-glycero-3-methoxypolyethylene
glycol-2000 (PEG2000 DMG), trometamol, trometamol hydrochloride, acetic acid, sodium
acetate </span><span class=MsoCommentReference><span lang=EN-GB>trihydrate</span></span><span
lang=EN-GB>, sucrose, water for injections.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><b><span
lang=EN-GB>What COVID-19 Vaccine Moderna looks like and contents of the pack</span></b></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>COVID-19 Vaccine Moderna is a white to off white dispersion </span><span
lang=EN-GB>supplied in a glass vial with a rubber stopper and aluminium seal. </span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Pack size: 10
multidose vials</span></p>

<p class=paragraph style='margin:0in;vertical-align:baseline'><span class=eop><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></span></p>

<p class=paragraph style='margin:0in;vertical-align:baseline'><b><span
style='font-size:11.0pt'>Marketing Authorisation Holder</span></b><span
class=eop><b><span lang=EN-GB style='font-size:11.0pt'>:</span></b></span></p>

<p class=paragraph style='margin:0in;vertical-align:baseline'><span
class=normaltextrun><span lang=SV style='font-size:11.0pt'>MODERNA BIOTECH
SPAIN, S.L.</span></span><span class=eop><span lang=SV style='font-size:11.0pt'>&nbsp;</span></span></p>

<p class=paragraph style='margin:0in;vertical-align:baseline'><span
class=normaltextrun><span lang=ES-TRAD style='font-size:11.0pt'>Calle
Monte&nbsp;Esquinza&nbsp;30</span></span></p>

<p class=paragraph style='margin:0in;vertical-align:baseline'><span
class=normaltextrun><span lang=ES style='font-size:11.0pt'>28010 Madrid</span></span><span
class=eop><span lang=ES style='font-size:11.0pt'>&nbsp;</span></span></p>

<p class=paragraph style='margin:0in;vertical-align:baseline'><span class=eop><span
lang=ES-TRAD style='font-size:11.0pt'>Spain</span></span></p>

<p class=paragraph style='margin:0in;vertical-align:baseline'><span class=eop><span
lang=ES-TRAD style='font-size:11.0pt'>&nbsp;</span></span></p>

<p class=paragraph style='margin:0in;vertical-align:baseline'><span class=eop><b><span
lang=ES-TRAD style='font-size:11.0pt'>Manufacturer:</span></b></span></p>

<p class=paragraph style='margin:0in;vertical-align:baseline'><span
lang=ES-TRAD style='font-size:11.0pt'>Rovi Pharma Industrial Services, S.A. </span></p>

<p class=paragraph style='margin:0in;vertical-align:baseline'><span
lang=ES-TRAD style='font-size:11.0pt'>Paseo de Europa, 50</span></p>

<p class=paragraph style='margin:0in;vertical-align:baseline'><span
lang=ES-TRAD style='font-size:11.0pt'>28703. San Sebastián de los Reyes</span></p>

<p class=paragraph style='margin:0in;vertical-align:baseline'><span lang=EN-GB
style='font-size:11.0pt'>Madrid, Spain</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>For any information about this medicine, please contact the local
representative of the Marketing Authorisation Holder.</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=624
 style='margin-left:-1.7pt;border-collapse:collapse'>
 <tr style='height:.6in'>
  <td style='border:none;padding:0in 0in 0in 0in' width=2><p class='MsoNormal'>&nbsp;</td>
  <td width=310 valign=top style='width:232.2pt;padding:0in 5.4pt 0in 5.4pt;
  height:.6in'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=FR>België/Belgique/Belgien</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=FR>Tél/Tel: +3280038405</span></p>
  <p class=MsoNormal style='margin-right:1.7pt;line-height:normal'><span
  lang=FR>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt;
  height:.6in'>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><b><span
  lang=EN-GB>Lietuva</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=IT>Tel: </span>+37080023365</p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=IT>&nbsp;</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=IT>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td style='border:none;padding:0in 0in 0in 0in' width=2><p class='MsoNormal'>&nbsp;</td>
  <td width=310 valign=top style='width:232.2pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><b><span
  lang=EN-GB>&#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></p>
  <p class=MsoNormal style='line-height:normal;text-autospace:none'><span
  lang=IT>Te</span><span lang=EN-GB>&#1083;</span><span lang=IT>.: +3598002100471</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=IT>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=IT>Luxembourg/Luxemburg</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=FR>Tél/Tel: </span>+35280026532</p>
  </td>
 </tr>
 <tr style='height:.5in'>
  <td style='border:none;padding:0in 0in 0in 0in' width=2><p class='MsoNormal'>&nbsp;</td>
  <td width=310 valign=top style='width:232.2pt;padding:0in 5.4pt 0in 5.4pt;
  height:.5in'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&#268;eská
  republika</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +</span>800050719</p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt;
  height:.5in'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Magyarország</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel.: </span>+3680088442</p>
  </td>
 </tr>
 <tr>
  <td style='border:none;padding:0in 0in 0in 0in' width=2><p class='MsoNormal'>&nbsp;</td>
  <td width=310 valign=top style='width:232.2pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Danmark</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tlf: +</span>4580830153</p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Malta</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: </span>+35680062397</p>
  </td>
 </tr>
 <tr>
  <td style='border:none;padding:0in 0in 0in 0in' width=2><p class='MsoNormal'>&nbsp;</td>
  <td width=310 valign=top style='width:232.2pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=DE>Deutschland</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: </span>08001009632</p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Nederland</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: </span>8004090001</p>
  </td>
 </tr>
 <tr>
  <td style='border:none;padding:0in 0in 0in 0in' width=2><p class='MsoNormal'>&nbsp;</td>
  <td width=310 valign=top style='width:232.2pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Eesti</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel</span>+3728000032166</p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Norge</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tlf: </span>80031401</p>
  </td>
 </tr>
 <tr>
  <td style='border:none;padding:0in 0in 0in 0in' width=2><p class='MsoNormal'>&nbsp;</td>
  <td width=310 valign=top style='width:232.2pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EL>&#917;&#955;&#955;&#940;&#948;&#945;</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EL>&#932;&#951;&#955;:
  +</span>308003212876</p>
  <p class=MsoNormal style='line-height:normal'><span lang=EL>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=DE>Österreich</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: </span>+43800232927</p>
  </td>
 </tr>
 <tr>
  <td width=312 colspan=2 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=ES-TRAD>España</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: </span>900031015</p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=PL>Polska</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel.: </span>+488003211487</p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 colspan=2 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>France</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=FR>Tél: </span>0805543016</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=PT>Portugal</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=PT>Tel: </span>800210256</p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>România</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: </span>+40800630047</p>
  </td>
 </tr>
 <tr>
  <td width=312 colspan=2 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'><span
  lang=PT style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
  clear=all style='page-break-before:always'>
  </span>
  <p class=MsoNormal style='line-height:normal'><b><span lang=PT>Hrvatska</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=NO-BOK>Tel: </span>8009614</p>
  <p class=MsoNormal style='line-height:normal'><span lang=NO-BOK>&nbsp;</span></p>
  <p class=MsoNormal style='line-height:normal'><b><span lang=NO-BOK>Ireland</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +</span>3531800851200</p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Slovenija</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: </span>+38680488802</p>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=312 colspan=2 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Ísland</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Sími: </span>8004382</p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Slovenská
  republika</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: +421800105207</span></p>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB
  style='color:green'>&nbsp;</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=312 colspan=2 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=IT>Italia</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=IT>Tel: </span>+39800141758</p>
  <p class=MsoNormal style='line-height:normal'><b><span lang=IT>&nbsp;</span></b></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=SV>Suomi/Finland</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=SV>Puh/Tel: </span>+358800413854</p>
  </td>
 </tr>
 <tr>
  <td width=312 colspan=2 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EL>&#922;&#973;&#960;&#961;&#959;&#962;</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EL>&#932;&#951;&#955;:</span>
  +35780077065</p>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EL>&nbsp;</span></b></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Sverige</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: </span>+4620127022</p>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=312 colspan=2 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>Latvija</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=PT>Tel: </span>+37180005882</p>
  <p class=MsoNormal style='line-height:normal'><span lang=PT>&nbsp;</span></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>United Kingdom
  (Northern Ireland)</span></b></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Tel: </span><span
  lang=EN-GB>08000857562</span></p>
  <p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=312 colspan=2 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>
  </td>
  <td width=312 valign=top style='width:233.9pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='line-height:normal'><b><span lang=EN-GB>&nbsp;</span></b></p>
  </td>
 </tr>
 <tr height=0>
  <td width=2 style='border:none'></td>
  <td width=310 style='border:none'></td>
  <td width=312 style='border:none'></td>
 </tr>
</table>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>This leaflet was last revised in
{MM/YYYY}</span></b><b><span lang=EN-GB>.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>This vaccine has been given ‘conditional approval’. This means that
there is more evidence to come about this vaccine.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>The European Medicines Agency will review new information on this vaccine
at least every year and this leaflet will be updated as necessary.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=paragraph style='margin-top:0in;margin-right:-.75pt;margin-bottom:
0in;margin-left:0in;page-break-after:avoid;vertical-align:baseline'><span
lang=EN-GB style='font-size:9.0pt;font-family:"Segoe UI",sans-serif'>&nbsp;</span></p>

<p class=paragraph style='margin-top:0in;margin-right:-.75pt;margin-bottom:
0in;margin-left:0in;page-break-after:avoid;vertical-align:baseline'><span
class=normaltextrun><span lang=EN-GB style='font-size:11.0pt'>Scan the code
with a mobile device to get the package leaflet in different languages.</span></span><span
class=eop><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></span></p>

<p class=paragraph style='margin-top:0in;margin-right:-.75pt;margin-bottom:
0in;margin-left:0in;vertical-align:baseline'><span class=eop><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></span></p>

<p class=paragraph style='margin-top:0in;margin-right:-.75pt;margin-bottom:
0in;margin-left:0in;vertical-align:baseline'><span lang=DE><img border=0
width=124 height=124 id="Picture 3"
src="COVID-19%20Vaccine%20Moderna%205791%20-%20Product%20Information%20final_files/image010.jpg"></span><span
class=eop><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></span></p>

<p class=paragraph style='margin-top:0in;margin-right:-.75pt;margin-bottom:
0in;margin-left:0in;vertical-align:baseline'><span class=eop><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></span></p>

<p class=paragraph style='margin-top:0in;margin-right:-.75pt;margin-bottom:
0in;margin-left:0in;vertical-align:baseline'><span class=normaltextrun><span
lang=EN-GB style='font-size:11.0pt'>Or visit the URL&nbsp;</span></span><a
href="https://www.modernacovid19global.com/" target="_blank"><span
class=normaltextrun><span lang=EN-GB style='font-size:11.0pt;color:black;
background:#E1E3E6;text-decoration:none'>https://www.ModernaCovid19Global.com</span></span></a><span
class=eop><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>Detailed information on this vaccine is available on the European
Medicines Agency web site: <span class=MsoHyperlink>http://www.ema.europa.eu</span>.
</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>This leaflet is available in all EU/EEA languages on the European
Medicines Agency website.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>------------------------------------------------------------------------------------------------------------------------</span></p>

<p class=MsoNormal style='margin-right:-1.4pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.4pt;margin-bottom:
0in;margin-left:-1.85pt;margin-bottom:.0001pt;line-height:normal'><b><span
lang=EN-GB>The following information is intended for healthcare professionals
only:</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-1.4pt;margin-bottom:
0in;margin-left:-1.85pt;margin-bottom:.0001pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><u><span lang=EN-GB>Traceability </span></u></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>In order to
improve the traceability of biological medicinal products, the name and the
batch number</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;line-height:
normal'><span lang=EN-GB>of the administered product should be clearly
recorded. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>COVID-19 Vaccine
Moderna should be administered by a trained healthcare professional. </span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>The vaccine
comes ready to use once thawed.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>Do not shake or
dilute.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>COVID-19 Vaccine
Moderna vials </span><span lang=EN-GB>are multidose. Ten (10) doses can be
withdrawn from each multidose vial.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>An additional
overfill is included in each vial to ensure that 10 doses of 0.5&nbsp;mL can be
delivered.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>COVID-19 Vaccine Moderna should be administered as two 0.5 mL doses.
It is recommended to administer the second dose 28 days after the first dose.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>As with all injectable vaccines, appropriate medical treatment and
supervision must always be</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>readily available in the event of an anaphylactic reaction following
the administration of</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>COVID-19 Vaccine</span><span lang=EN-GB> </span><span lang=EN-GB>Moderna.
Individuals should be observed by a healthcare professional for at least 15
minutes after vaccination.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
class=normaltextrun><span lang=EN-GB style='color:black;border:none windowtext 1.0pt;
padding:0in'>There are no data to assess the concomitant administration of
COVID-19 Vaccine Moderna with other vaccines.</span></span><span lang=EN-GB
style='font-family:"Arial",sans-serif;color:black;background:white'> </span><span
lang=EN-GB>COVID-19 Vaccine Moderna must not be mixed with other vaccines or
medicinal products in the same syringe.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>The vaccine must </span><span lang=EN-GB>be administered intramuscularly.
The preferred site is the deltoid muscle of the upper arm. Do not administer
this vaccine intravascularly, subcutaneously or intradermally.</span></p>

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB>Information about storage and handling</span></b></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE><img border=0
width=605 height=144 id="Picture 2"
src="COVID-19%20Vaccine%20Moderna%205791%20-%20Product%20Information%20final_files/image011.png"></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE><img border=0
width=604 height=171 id="Picture 600170359"
src="COVID-19%20Vaccine%20Moderna%205791%20-%20Product%20Information%20final_files/image012.png"></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE><img border=0
width=604 height=326 id="Picture 190092424"
src="COVID-19%20Vaccine%20Moderna%205791%20-%20Product%20Information%20final_files/image013.png"></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=DE><img border=0
width=604 height=295 id="Picture 1387647513"
src="COVID-19%20Vaccine%20Moderna%205791%20-%20Product%20Information%20final_files/image014.png"></span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='line-height:normal;page-break-after:avoid'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:6.0pt;margin-bottom:0in;
margin-left:6.35pt;margin-bottom:.0001pt;text-autospace:none'><span lang=EN-GB
style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:6.0pt;margin-bottom:0in;
margin-left:6.35pt;margin-bottom:.0001pt;text-autospace:none'><span lang=EN-GB
style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:6.0pt;margin-bottom:0in;
margin-left:6.35pt;margin-bottom:.0001pt;text-autospace:none'><span lang=EN-GB
style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:6.0pt;margin-bottom:0in;
margin-left:6.35pt;margin-bottom:.0001pt;text-autospace:none'><span lang=EN-GB
style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:6.0pt;margin-bottom:0in;
margin-left:6.35pt;margin-bottom:.0001pt;text-autospace:none'><span lang=EN-GB
style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:6.0pt;margin-bottom:0in;
margin-left:6.35pt;margin-bottom:.0001pt;text-autospace:none'><span lang=EN-GB
style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:6.0pt;margin-bottom:0in;
margin-left:6.35pt;margin-bottom:.0001pt;text-autospace:none'><span lang=EN-GB
style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:6.0pt;margin-bottom:0in;
margin-left:6.35pt;margin-bottom:.0001pt;text-autospace:none'><span lang=EN-GB
style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:6.0pt;margin-bottom:0in;
margin-left:6.35pt;margin-bottom:.0001pt;text-autospace:none'><span lang=EN-GB
style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:6.0pt;margin-bottom:0in;
margin-left:6.35pt;margin-bottom:.0001pt;text-autospace:none'><span lang=EN-GB
style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:6.0pt;margin-bottom:0in;
margin-left:6.35pt;margin-bottom:.0001pt;text-autospace:none'><span lang=EN-GB
style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:6.0pt;margin-bottom:0in;
margin-left:6.35pt;margin-bottom:.0001pt;text-autospace:none'><span lang=EN-GB
style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:6.0pt;margin-bottom:0in;
margin-left:6.35pt;margin-bottom:.0001pt;text-autospace:none'><span lang=EN-GB
style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:6.0pt;margin-bottom:0in;
margin-left:6.35pt;margin-bottom:.0001pt;text-autospace:none'><span lang=EN-GB
style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:6.0pt;margin-bottom:0in;
margin-left:6.35pt;margin-bottom:.0001pt;text-autospace:none'><span lang=EN-GB
style='color:black'>&nbsp;</span></p>

<p class=MsoNormal align=center style='margin-top:14.0pt;margin-right:6.0pt;
margin-bottom:0in;margin-left:6.35pt;margin-bottom:.0001pt;text-align:center;
page-break-after:avoid;text-autospace:none'><b><span lang=EN-GB
style='color:black'>Annex IV</span></b></p>

<p class=MsoNormal align=center style='margin-top:14.0pt;margin-right:6.0pt;
margin-bottom:11.0pt;margin-left:6.35pt;text-align:center;page-break-after:
avoid;text-autospace:none'><b><span lang=EN-GB style='color:black'>Conclusions
on the granting of the conditional marketing authorisation presented by the
European Medicines Agency</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:6.0pt;margin-bottom:0in;
margin-left:6.35pt;margin-bottom:.0001pt;text-autospace:none'><span lang=EN-GB
style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:14.0pt;margin-right:6.0pt;margin-bottom:
0in;margin-left:6.35pt;margin-bottom:.0001pt;page-break-after:avoid;text-autospace:
none'><span lang=EN-GB style='color:black'>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-top:14.0pt;margin-right:6.0pt;margin-bottom:
11.0pt;margin-left:6.35pt;page-break-after:avoid;text-autospace:none'><b><span
lang=EN-GB style='color:black'>Conclusions presented by the European Medicines
Agency on:</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:7.0pt;
margin-left:25.25pt;text-indent:-19.85pt;line-height:14.0pt;text-autospace:
none'><span lang=EN-GB style='font-size:12.0pt;font-family:Symbol;color:black'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='color:black'>Conditional marketing
authorisation</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:6.0pt;margin-bottom:7.0pt;
margin-left:6.35pt;line-height:14.0pt;text-autospace:none'><span lang=EN-GB
style='color:black'>The CHMP having considered the application is of the
opinion that the risk-benefit balance is favourable to recommend the granting
of the conditional marketing authorisation as further explained in the European
Public Assessment Report.</span></p>

<p class=MsoNormal style='margin-right:-.1pt;line-height:normal'><span
lang=EN-GB>&nbsp;</span></p>

</div>

</body>

</html>
